A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT00424476 · COMPLETED

Trial details

NCT number: NCT00424476
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2007-05-01
Primary completion: 2009-05-01
Enrollment: 865

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.